The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Brugger Stephen B since 2006.
The trader's CIK number is 1294347.
At the time of the last reporting, Brugger Stephen B was the Chief Operating Offi of Momenta Pharmaceuticals Inc. (stock ticker symbol MNTA).
Also see all insider trading activities at Momenta Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2010 | MNTA | 0 | $0 | 88,452 | $1,577,909 | 55,730 | $12,873 |
| 2009 | MNTA | 0 | $0 | 827 | $8,449 | 0 | $0 |
| 2006 | MNTA | 0 | $0 | 29,970 | $735,913 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-10-28 | MNTA | Option Ex | 55,730 | .23 | 12,873 |
| 2010-08-26 | MNTA | Sale | 457 | 16.57 | 7,572 |
| 2010-08-24 | MNTA | Sale | 134 | 15.22 | 2,039 |
| 2010-08-03 | MNTA | Sale | 18,300 | 21.92 | 401,136 |
| 2010-08-04 | MNTA | Sale | 13,100 | 20.85 | 273,135 |
| 2010-08-05 | MNTA | Sale | 13,896 | 18.16 | 252,351 |
| 2010-05-26 | MNTA | Sale | 457 | 12.45 | 5,689 |
| 2010-05-26 | MNTA | Sale | 457 | 12.45 | 5,689 |
| 2010-05-25 | MNTA | Sale | 136 | 11.56 | 1,572 |
| 2010-03-10 | MNTA | Sale | 7,800 | 15.13 | 118,014 |
| 2010-03-08 | MNTA | Sale | 15,352 | 15.17 | 232,889 |
| 2010-03-09 | MNTA | Sale | 16,848 | 15.17 | 255,584 |
| 2010-03-01 | MNTA | Sale | 1,413 | 14.65 | 20,700 |
| 2010-02-23 | MNTA | Sale | 102 | 15.09 | 1,539 |
| 2009-08-24 | MNTA | Sale | 102 | 9.82 | 1,001 |
| 2009-11-24 | MNTA | Sale | 103 | 10.53 | 1,084 |
| 2009-05-22 | MNTA | Sale | 100 | 8.52 | 852 |
| 2009-02-23 | MNTA | Sale | 522 | 10.56 | 5,512 |
| 2006-02-17 | MNTA | Sale | 29,970 | 24.55 | 735,913 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Brugger Stephen B (Chief Operating Offi of Momenta Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.